Jean-Yves Douillard - Articles and news items

Amgen logo

Analysis published in New England Journal of Medicine highlights discovery of new predictive biomarkers for Vectibix® (panitumumab)

Industry news, News / 11 September 2013 / Amgen

Study links RAS mutations to Vectibix clinical response in patients with metastatic colorectal cancer…

Amgen logo

Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union

Industry news, News / 15 November 2011 / Amgen

The EC has approved a variation to the marketing authorization for Vectibix®…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+